Transcat, Inc. (NASDAQ:TRNS) Holdings Raised by US Bancorp DE

US Bancorp DE increased its stake in Transcat, Inc. (NASDAQ:TRNS) by 15.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,547 shares of the scientific and technical instruments company’s stock after purchasing an additional 209 shares during the quarter. US Bancorp DE’s holdings in Transcat were worth $187,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Hood River Capital Management LLC boosted its stake in Transcat by 21.6% in the 2nd quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock worth $23,558,000 after purchasing an additional 34,947 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in shares of Transcat by 28.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after buying an additional 17,743 shares during the period. Raymond James & Associates grew its holdings in shares of Transcat by 157.2% during the third quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock valued at $2,494,000 after buying an additional 12,622 shares in the last quarter. Janus Henderson Group PLC raised its position in Transcat by 208.3% during the first quarter. Janus Henderson Group PLC now owns 10,297 shares of the scientific and technical instruments company’s stock valued at $1,147,000 after buying an additional 6,957 shares during the period. Finally, Calamos Advisors LLC raised its position in Transcat by 76.0% during the second quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock valued at $1,848,000 after buying an additional 6,667 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Craig Hallum lowered their target price on Transcat from $138.00 to $113.00 and set a “buy” rating on the stock in a research note on Wednesday, October 30th. Oppenheimer reaffirmed an “outperform” rating and set a $130.00 price objective (down from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. Northland Securities dropped their price objective on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 30th. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price target on shares of Transcat in a research note on Tuesday, October 29th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, Transcat presently has an average rating of “Hold” and an average price target of $127.25.

Transcat Stock Performance

Shares of TRNS opened at $108.03 on Friday. The firm has a market cap of $993.88 million, a PE ratio of 54.56 and a beta of 0.69. The firm’s 50 day moving average price is $118.56 and its 200 day moving average price is $121.68. Transcat, Inc. has a twelve month low of $89.39 and a twelve month high of $147.12.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The business had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. Transcat had a net margin of 6.63% and a return on equity of 7.36%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.41 EPS. On average, sell-side analysts anticipate that Transcat, Inc. will post 1.76 earnings per share for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.